Breast Biopsy Market Forecast Reaching $2.03 Billion by 2029 at 7.3% CAGR
Discover trends, market shifts, and competitive outlooks for the breast biopsy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Is the Estimated Market Size of the Breast Biopsy Market In 2029?
Over the past few years, a considerable surge has been observed in the size of the breast biopsy market. It is anticipated to expand from $1.42 billion in 2024 to $1.53 billion in 2025, showing a Compound Annual Growth Rate (CAGR) of 7.6%. This significant growth during the historic period is ascribed primarily to the escalating instances of breast cancer, a burgeoning aging population, extensive awareness programs, enlarged healthcare spending, and a transition towards ambulatory and outpatient settings.
In the coming years, the breast biopsy market size stands to witness substantial expansion. By 2029, a growth rate of 7.3% will drive the market to reach a value of $2.03 billion. This predicted growth in the market for the forecast period can be credited to several factors. These include healthcare sector infrastructure progression, the popularity of personalized medicine, the elevated healthcare access in developing regions, the adoption of supportive regulations and reimbursement policies, as well as the advancements in telemedicine and remote diagnostics. Key trends expected during the forecast period encompass the incorporation of robotics into biopsy procedures, the surge in home-based biopsy kits, the rising significance of genomic biopsies, the focus on patient-centric care models,, securing data through blockchain, and the emphasis on post-biopsy monitoring instruments.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19348&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Breast Biopsy Market?
The escalating incidence of breast cancer is anticipated to stimulate the expansion of the breast biopsy market. Breast cancer, a harmful tumor originating in the cells of the breast tissue, has the potential to metastasize to various body parts if it lacks prompt treatment. The surging incidence of this deadly disease is associated with factors like enhanced life span, advanced detection techniques, and heightened consciousness about the ailment. A breast biopsy procedure is adopted to extract tissue samples from questionable regions of the breast to diagnose and delineate the properties of breast cancer. For instance, as per the American Cancer Society, a non-profit entity based in the US, the count of newly emerging invasive breast cancer incidents in American females ascended from roughly 281,550 in 2021 to 297,790 in 2023 during January. Consequently, this increasing incidence of breast cancer is fueling the expansion of the breast biopsy market.
Which Key Market Segments Comprise the Breast Biopsy Market and Drive Its Revenue Growth?
The breast biopsymarket covered in this report is segmented –
1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Breast Biopsy
3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications
Subsegments:
1) By Biopsy Needles: Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
2) By Guidance Systems: Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
3) By Biopsy Tables: Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
4) By Localization Wires: Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
5) By Assay Kits: Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
7) By Other Types: Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=19348&type=smp
Which Areas Are Leading Regions in the Breast Biopsy Market Expansion Across the Globe?
North America was the largest region in the breast biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in the Breast Biopsy Market Over the Coming Years?
Leading businesses active in the breast biopsy market are emphasizing the development of groundbreaking solutions, such as the vacuum-assisted breast biopsy system, to improve patient care, particularly those with benign lesions. A vacuum-assisted breast biopsy system employs suction technology to extract multiple tissue samples from a doubtful breast area via the singular insertion of a needle. For instance, Devicor Medical Products, Inc., a medical device company based in the U.S., introduced the Mammotome Revolve EX Dual Vacuum-Assisted Breast Biopsy System in August 2022. This system contains a dual vacuum mechanism to optimize tissue collection, providing improved exactness and increased volume sampling. It boasts an ergonomic design with a rotating probe for superior maneuverability and a one-time insertion approach to ease patient discomfort. The system also integrates real-time imaging for pinpoint targeting and efficient biopsy procedures.
View the full report here:
https://www.thebusinessresearchcompany.com/report/breast-biopsy-global-market-report
How Is the Breast Biopsy Market Conceptually Defined?
A breast biopsy is a medical procedure in which a small sample of breast tissue is removed and examined under a microscope to determine if it is cancerous or benign. It is typically performed when a lump or abnormality is detected in the breast through imaging tests or physical exams. The biopsy can be done using various methods, such as needle biopsy or surgical biopsy, often guided by imaging techniques such as ultrasound, and mammography.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19348
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model